LiveKidney.BIO
PrivateLast Round
Seed
Nov 18, 2018
Total Funding Raised
$4M
Company Overview
LiveKidney.BIO is a biotechnology company that develops proprietary, hydrogel-based cell therapy products to treat advanced kidney diseases and prevent their progression.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LiveKidney.BIO Comparables
Compare LiveKidney.BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trestle Biotherapeutics | 85% | |
| eGenesis | 77% | |
| United Therapeutics | 77% | |
LiveKidney.BIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 18, 2018 |
Key People
Founding team and executive leadership
LiveKidney.BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Direct Insurance - Financial Investments | Seed |
| Aurum Ventures MKI | Seed |
LiveKidney.BIO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LiveKidney.BIO's valuation, stock price, and market status.